Three-component research blend

GLOW

GHK-Cu, BPC-157 and Thymosin Beta-4 combined in a documented 70 mg research format.

Explore presentation-specific analytical records covering identity, purity, measured content, lot traceability and downloadable Certificates of Analysis.

Certified presentations
Product information
Royal Pharma GLOW vial
Selected record70 mg

Product-family image supplied by Royal Pharma. Certified presentations are identified by their individual COA records below.

Product authentication

Authenticity, built into every product.

Powered by NFC. Secured by blockchain. Verified instantly.

Each Royal Pharma product carries a unique NFC-enabled microchip connected to the brand's proprietary blockchain authentication environment, creating a secure, traceable and tamper-resistant digital identity.

01
Unique identity

A product-linked NFC identity designed for one-tap verification.

02
Secure verification

A blockchain-secured record supporting authenticity and traceability.

03
Batch documentation

Presentation-specific COAs document identity, purity, measured content and lot information.

Product information

Three research components, one batch record.

GLOW combines GHK-Cu, BPC-157 and Thymosin Beta-4 in a 50 / 10 / 10 mg format. The supplied COA separately reports measured content for all three components and identifies the submitted sample as a blue lyophilised powder.

01

Research class

GHK-Cu / BPC-157 / Thymosin Beta-4 blend
02

Documentation status

Investigational research blend
03

Reference CAS

Per component
04

Physical form

Blue lyophilised powder

Research profile

Three components across matrix and cell-response research.

The formulation brings together a copper peptide, a synthetic gastric peptide and a Thymosin Beta-4 component. No controlled study of the three-component combination is established; each arm is presented as research context only.

GHK-Cu
GHK-Cu · 50 mg

Copper-binding tripeptide component associated with matrix and expression research.

BPC-157
BPC-157 · 10 mg

Synthetic 15-residue component used in preclinical tissue-response models.

TB-4
Thymosin Beta-4 · 10 mg

Actin-binding peptide component studied in cell-migration and wound-model research.

Quality documentation

Certificate of Analysis

Choose a presentation to display the exact analytical record
supplied for that sample.

Select presentation
Selected COA

GLOW · 70 mg

Purity99.84%
Measured content
GHK-Cu 49.97 mg / BPC-157 11.10 mg / Thymosin Beta-4 10.14 mg
Identity
GHK-Cu / BPC-157 / Thymosin Beta-4
Lot
GLOW-4172
Appearance
Blue Lyophilized Powder
Accession number
2606290375
Search code
Received
04/17/2025
Reported
4/18/2025
For laboratory research use only.

The supplied certificates state that the tested materials are intended for research use only and are not approved for human or veterinary use, diagnostic, therapeutic or clinical applications. Results are specific to the submitted samples. This page does not provide medical advice, dosing or administration instructions.